| Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network—United States, March–June 2020 MW Tenforde MMWR. Morbidity and mortality weekly report 69, 2020 | 1490 | 2020 |
| Association between mRNA vaccination and COVID-19 hospitalization and disease severity MW Tenforde, WH Self, K Adams, M Gaglani, AA Ginde, T McNeal, ... Jama 326 (20), 2043-2054, 2021 | 610 | 2021 |
| Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study AS Lauring, MW Tenforde, JD Chappell, M Gaglani, AA Ginde, T McNeal, ... bmj 376, 2022 | 574 | 2022 |
| Comparative effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) vaccines in preventing COVID-19 hospitalizations among adults without immunocompromising … WH Self MMWR. Morbidity and mortality weekly report 70, 2021 | 481 | 2021 |
| The low density lipoprotein receptor-related protein (LRP) is a novel β-secretase (BACE1) substrate CAF Von Arnim, A Kinoshita, ID Peltan, MM Tangredi, L Herl, BM Lee, ... Journal of Biological Chemistry 280 (18), 17777-17785, 2005 | 344 | 2005 |
| Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study BJ Webb, ID Peltan, P Jensen, D Hoda, B Hunter, A Silver, N Starr, ... The Lancet Rheumatology 2 (12), e754-e763, 2020 | 318 | 2020 |
| Community and close contact exposures associated with COVID-19 among symptomatic adults≥ 18 years in 11 outpatient health care facilities—United States, July 2020 KA Fisher MMWR. Morbidity and mortality weekly report 69, 2020 | 258 | 2020 |
| Sustained effectiveness of Pfizer-BioNTech and Moderna vaccines against COVID-19 associated hospitalizations among adults—United States, March–July 2021 MW Tenforde MMWR. Morbidity and mortality weekly report 70, 2021 | 248 | 2021 |
| Seroprevalence of SARS-CoV-2 among frontline health care personnel in a multistate hospital network—13 academic medical centers, April–June 2020 WH Self MMWR. Morbidity and mortality weekly report 69, 2020 | 241 | 2020 |
| Interaction of the cytosolic domains of sorLA/LR11 with the amyloid precursor protein (APP) and β-secretase β-site APP-cleaving enzyme R Spoelgen, CAF Von Arnim, AV Thomas, ID Peltan, M Koker, A Deng, ... Journal of Neuroscience 26 (2), 418-428, 2006 | 220 | 2006 |
| Effect of vitamin C, thiamine, and hydrocortisone on ventilator-and vasopressor-free days in patients with sepsis: the VICTAS randomized clinical trial JE Sevransky, RE Rothman, DN Hager, GR Bernard, SM Brown, ... Jama 325 (8), 742-750, 2021 | 212 | 2021 |
| ED door-to-antibiotic time and long-term mortality in sepsis ID Peltan, SM Brown, JR Bledsoe, J Sorensen, MH Samore, TL Allen, ... Chest 155 (5), 938-946, 2019 | 188 | 2019 |
| Decline in SARS-CoV-2 antibodies after mild infection among frontline health care personnel in a multistate hospital network—12 states, April–August 2020 WH Self MMWR. Morbidity and mortality weekly report 69, 2020 | 156 | 2020 |
| Effectiveness of SARS-CoV-2 mRNA vaccines for preventing Covid-19 hospitalizations in the United States MW Tenforde, MM Patel, AA Ginde, DJ Douin, HK Talbot, JD Casey, ... MedRxiv, 2021 | 155 | 2021 |
| Effectiveness of mRNA vaccination in preventing COVID-19–associated invasive mechanical ventilation and death—United States, March 2021–January 2022 MW Tenforde MMWR. Morbidity and mortality weekly report 71, 2022 | 154 | 2022 |
| Demonstration of BACE (β-secretase) phosphorylation and its interaction with GGA1 in cells by fluorescence-lifetime imaging microscopy CAF von Arnim, MM Tangredi, ID Peltan, BM Lee, MC Irizarry, A Kinoshita, ... Journal of cell science 117 (22), 5437-5445, 2004 | 141 | 2004 |
| An international normalized ratio–based definition of acute traumatic coagulopathy is associated with mortality, venous thromboembolism, and multiple organ failure after injury ID Peltan, LKV Vusse, RV Maier, TR Watkins Critical care medicine 43 (7), 1429-1438, 2015 | 138 | 2015 |
| Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised … WH Self, U Sandkovsky, CS Reilly, DM Vock, RL Gottlieb, M Mack, ... The Lancet Infectious Diseases 22 (5), 622-635, 2022 | 125 | 2022 |
| Early estimates of bivalent mRNA vaccine effectiveness in preventing COVID-19–associated hospitalization among immunocompetent adults aged≥ 65 years—IVY Network, 18 states … D Surie MMWR. Morbidity and mortality weekly report 71, 2022 | 98 | 2022 |
| Effectiveness of a third dose of Pfizer-BioNTech and Moderna vaccines in preventing COVID-19 hospitalization among immunocompetent and immunocompromised adults—United States … MW Tenforde MMWR. Morbidity and mortality weekly report 71, 2022 | 96 | 2022 |
Samuel M. BrownProfessor of Medicine, Intermountain Medical Center and University of Utah在 hsc.utah.edu 的电子邮件经过验证
